Apr 22, 2020
Influenzavirus B Infections - Pipeline Review, H1 2020
Apr 15, 2020
Fujifilm accelerates production of its influenza antiviral drug "Avigan® Tablet" for COVID-19
Apr 06, 2020
The global influenza vaccine market is estimated to record a CAGR of 6.43% over the forecast period of 2020-2028
Mar 31, 2020
Isenolic Olive Leaf Extract Helps Halt Viral Lifecycle
Aug 31, 2019
Seqirus Presents New Scientific Data Comparing Circulating Influenza B Viruses With Both Cell-Based and Egg-Based Influenza B Reference Viruses
Aug 22, 2019
Seqirus to Present Data on Pandemic and Seasonal Influenza Vaccines at OPTIONS X Conference
Jul 24, 2019
Global Influenza Diagnostics Market 2019-2023
Jun 14, 2019
Breakthrough! New Study Reveals How Humidification Provides Protection from Influenza Disease
May 16, 2019
Kanazawa University Research: Virulence Factor of the Influenza A Virus Mapped in Real-time
Apr 30, 2019
510(k) Market Clearance for FluChip-8G Influenza A+B Assay
Apr 15, 2019
Seqirus Announces Further Advances in Cell-Based Influenza Vaccine Technology
Nov 16, 2018
Seqirus Announces U.S. $140 Million Manufacturing Expansion to Meet Growing Demand for Innovative Cell-Based Influenza Vaccines
Nov 16, 2018
Seqirus Releases Real-World Data Indicating Significantly Greater Effectiveness of Cell-Based Seasonal Influenza Vaccines Compared to Standard Influenza Vaccine Options
Nov 13, 2018
U.S. Influenza Diagnostics Market Worth USD 865.4 Million by 2024: Hexa Research
Oct 03, 2018
Seqirus Presents Data at IDWeek Demonstrating Cell-Derived Viruses Have a Closer Match to Circulating Influenza Viruses Compared to Egg-derived Viruses Used in the Production of Influenza Vaccines
May 21, 2018
Groundbreaking Global Initiative on Sharing All Influenza Data (GISAID) Celebrates Tenth Anniversary
Feb 06, 2018
Global Swine and Avian Influenza Drug Development Pipeline Review 2017 Featuring Gemmus Pharma, Aphios, Fides Pharma, Inovio, Microbiotix, NanoViricides, Shionogi and Tria Bioscience
Dec 19, 2017
Global Influenza Vaccine Markets 2017-2023 - Major Players for the $4.6 Bn Market are Seqirus, GlaxoSmithKilne, Sanofi Pasteur, and Merck Sharp & Dohme
Oct 17, 2017
American Family Care Launches Anti-Flu Campaign
Sep 13, 2017
S-033188 Phase 3 CAPSTONE-1 Study Results for Treatment of Influenza Presented at the European Scientific Working Group on Influenza Conference